Marksans Pharma (NSE:MARKSANS) Other Long-Term Liabilities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Other Long-Term Liabilities?

Marksans Pharma's other long-term liabilities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Marksans Pharma's quarterly other long-term liabilities increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹228 Mil) but then declined from Sep. 2023 (₹228 Mil) to Dec. 2023 (₹0 Mil).

Marksans Pharma's annual other long-term liabilities increased from Mar. 2021 (₹152 Mil) to Mar. 2022 (₹195 Mil) but then declined from Mar. 2022 (₹195 Mil) to Mar. 2023 (₹186 Mil).

Marksans Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Marksans Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Other Long-Term Liabilities Chart

Marksans Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Marksans Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Marksans Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Marksans Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Marksans Pharma (NSE:MARKSANS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

524404:India

Address

Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053

Website

http://www.marksanspharma.com

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines